5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 15.20▲ | 15.01▲ | 14.89▲ | 14.33▲ | 15.17▲ |
MA10 | 15.07▲ | 14.89▲ | 14.80▲ | 14.27▲ | 14.41▲ |
MA20 | 14.91▲ | 14.71▲ | 14.58▲ | 15.03▲ | 11.84▲ |
MA50 | 14.75▲ | 14.17▲ | 14.04▲ | 13.57▲ | 10.78▲ |
MA100 | 14.48▲ | 14.14▲ | 14.87▲ | 11.52▲ | 25.02▼ |
MA200 | 14.06▲ | 14.78▲ | 14.26▲ | 10.76▲ | 107.37▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.036▲ | 0.017▲ | 0.062▲ | -0.149▼ | 0.563▲ |
RSI | 68.720▲ | 66.300▲ | 66.526▲ | 54.956▲ | 57.094▲ |
STOCH | 96.122▲ | 74.401 | 76.755 | 42.514 | 61.901 |
WILL %R | -8.943▲ | -7.914▲ | -5.023▲ | -48.074 | -31.649 |
CCI | 104.313▲ | 207.370▲ | 147.605▲ | 24.946 | 61.542 |
Friday, September 12, 2025 07:54 AM
We feel now is a pretty good time to analyse Stem, Inc.'s ( NYSE:STEM ) business as it appears the company may be ...
|
Friday, September 12, 2025 01:30 AM
A Superior Option for Chronic Disease Therapy ,” was authored by Pete O'Heeron, Founder and Chief Executive Officer of FibroBiologics, and Hamid Khoja, Ph.D., Chief Scientific Officer. The editorial ...
|
Wednesday, September 10, 2025 02:29 PM
Initial Phase 2 RoAD trial results demonstrate improvements in brain-cell connectivity and health, with a favorable safety profile CAMBRIDGE, Mass., Sept. 10, 2025 /PRNewswire/ -- NeuroSense ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/09/25 | 14.98 | 15.35 | 14.60 | 15.19 | 186,554 |
12/09/25 | 14.73 | 14.85 | 14.13 | 14.80 | 111,237 |
11/09/25 | 13.18 | 14.88 | 13.18 | 14.60 | 226,225 |
10/09/25 | 14.23 | 14.29 | 13.14 | 13.18 | 169,121 |
09/09/25 | 13.64 | 14.00 | 13.1504 | 13.86 | 195,654 |
08/09/25 | 13.70 | 13.95 | 13.392 | 13.50 | 153,846 |
05/09/25 | 14.28 | 14.30 | 13.50 | 13.98 | 82,515 |
04/09/25 | 14.64 | 14.64 | 13.47 | 14.23 | 106,575 |
03/09/25 | 14.44 | 14.9147 | 14.17 | 14.49 | 181,367 |
02/09/25 | 14.77 | 14.9974 | 14.31 | 14.84 | 181,154 |
|
|
||||
|
|
||||
|
|